Skip to main content
Top
Published in: Pediatric Radiology 7/2015

01-07-2015 | Original Article

The role of ultrasound in the follow-up of children with differentiated thyroid cancer

Authors: Reza Vali, Marianna Rachmiel, Jill Hamilton, Mohamad El Zein, Jonathan Wasserman, Danny L. Costantini, Martin Charron, Alan Daneman

Published in: Pediatric Radiology | Issue 7/2015

Login to get access

Abstract

Background

Thyroid cancer is the most common endocrine malignancy with relatively good prognosis in children. However, unlike adults, children usually present with more advanced disease and have a higher local recurrence and distant metastases. Thus surveillance for recurrence is a major goal of long-term follow-up.

Objective

This retrospective study evaluates the diagnostic value of ultrasound (US) imaging in the post-therapy surveillance of children with differentiated thyroid cancer.

Materials and methods

We reviewed the charts of 54 children (40 girls; mean age 14.3 ± 3.6 years) with differentiated thyroid cancer treated with total or near-total thyroidectomy. Forty children (29 girls and 11 boys) who had routine follow-up US examinations (112 studies) were included for the evaluation of US accuracy in the follow-up of pediatric differentiated thyroid cancer. Histopathology, stimulated thyroglobulin determination, post-therapy whole-body iodine scan and clinical follow-up were used as the standards of reference.

Results

Mean period of follow-up was 34 months. The frequency of recurrence was 42% (17/40). Seventeen percent of the children had lung metastases either at presentation or on follow-up. In all cases of lung metastases, stimulated thyroglobulin level was greater than 10 ng/ml. The sensitivity was 85.7%, specificity 89.4%, negative predictive value 94.4% and positive predictive value 75% for US in detecting loco-regional recurrence in follow-up studies of pediatric differentiated thyroid cancer. In 17.3% (18/104) of studies, the results of stimulated thyroglobulin and US were discordant.

Conclusion

US showed very good sensitivity and specificity and a high negative predictive value for evaluation of loco-regional involvement in follow-up of pediatric differentiated thyroid cancer. Diagnostic whole-body iodine scan is indicated when serum anti-thyroglobulin Ab is high, or in cases of discordant findings between US and stimulated thyroglobulin levels, or when stimulated thyroglobulin levels are >10 ng/ml (to evaluate for lung metastasis).
Literature
2.
go back to reference Hogan AR, Zhuge Y, Perez EA et al (2009) Pediatric thyroid carcinoma: incidence and outcomes in 1,753 patients. J Surg Res 156:167–172PubMedCrossRef Hogan AR, Zhuge Y, Perez EA et al (2009) Pediatric thyroid carcinoma: incidence and outcomes in 1,753 patients. J Surg Res 156:167–172PubMedCrossRef
3.
go back to reference Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167PubMedCrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167PubMedCrossRef
4.
go back to reference Hundahl SA, Fleming ID, Fremgen AM et al (1998) A national cancer database report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83:2638–2648PubMedCrossRef Hundahl SA, Fleming ID, Fremgen AM et al (1998) A national cancer database report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83:2638–2648PubMedCrossRef
5.
go back to reference Mazzaferri EL, Massoll N (2002) Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 9:227–247PubMedCrossRef Mazzaferri EL, Massoll N (2002) Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 9:227–247PubMedCrossRef
7.
go back to reference Hay ID, Gonzalez-Losada T, Reinalda MS et al (2010) Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 34:1192–1202PubMedCrossRef Hay ID, Gonzalez-Losada T, Reinalda MS et al (2010) Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 34:1192–1202PubMedCrossRef
8.
go back to reference Parisi MT, Mankoff D (2007) Differentiated pediatric thyroid cancer: correlates with adult disease, controversies in treatment. Sem Nucl Med 37:340–356CrossRef Parisi MT, Mankoff D (2007) Differentiated pediatric thyroid cancer: correlates with adult disease, controversies in treatment. Sem Nucl Med 37:340–356CrossRef
9.
go back to reference Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef
10.
go back to reference O’Gorman CS, Hamilton J, Rachmiel M et al (2010) Thyroid cancer in childhood: a retrospective review of childhood course. Thyroid 20:375–380PubMedCrossRef O’Gorman CS, Hamilton J, Rachmiel M et al (2010) Thyroid cancer in childhood: a retrospective review of childhood course. Thyroid 20:375–380PubMedCrossRef
11.
go back to reference Ko MS, Lee JH, Shong YK et al (2010) Normal and abnormal sonographic findings at the thyroidectomy sites in postoperative patients with thyroid malignancy. AJR Am J Roentgenol 194:1596–1609PubMedCrossRef Ko MS, Lee JH, Shong YK et al (2010) Normal and abnormal sonographic findings at the thyroidectomy sites in postoperative patients with thyroid malignancy. AJR Am J Roentgenol 194:1596–1609PubMedCrossRef
12.
go back to reference Torlontano M, Attard M, Crocetti U et al (2004) Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402–3407PubMedCrossRef Torlontano M, Attard M, Crocetti U et al (2004) Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402–3407PubMedCrossRef
13.
go back to reference Antonelli A, Miccoli P, Fallahi P et al (2003) Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid 13:479–484PubMedCrossRef Antonelli A, Miccoli P, Fallahi P et al (2003) Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid 13:479–484PubMedCrossRef
14.
go back to reference Sohn YM, Kwak JY, Kim EK et al (2010) Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy. AJR Am J Roentgenol 194:38–43PubMedCrossRef Sohn YM, Kwak JY, Kim EK et al (2010) Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy. AJR Am J Roentgenol 194:38–43PubMedCrossRef
15.
go back to reference Leboulleux S, Girard E, Rose M et al (2007) Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 92:3590–3594PubMedCrossRef Leboulleux S, Girard E, Rose M et al (2007) Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 92:3590–3594PubMedCrossRef
16.
go back to reference Cailleux AF, Baudin E, Travagli JP et al (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175–178PubMedCrossRef Cailleux AF, Baudin E, Travagli JP et al (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175–178PubMedCrossRef
17.
go back to reference Lin JD, Chao TC, Hsueh C et al (2009) High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol 16:2609–2616PubMedCrossRef Lin JD, Chao TC, Hsueh C et al (2009) High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol 16:2609–2616PubMedCrossRef
19.
go back to reference Brassard M, Borget I, Edet-Sanson A et al (2011) Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab 96:1352–1359PubMedCrossRef Brassard M, Borget I, Edet-Sanson A et al (2011) Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab 96:1352–1359PubMedCrossRef
20.
go back to reference Collini P, Mattavelli F, Pellegrinelli A et al (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30:1420–1426PubMedCrossRef Collini P, Mattavelli F, Pellegrinelli A et al (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30:1420–1426PubMedCrossRef
21.
go back to reference Merrick Y, Hansen HS (1989) Thyroid cancer in children and adolescents in Denmark. Eur J Surg Oncol 15:49–53PubMed Merrick Y, Hansen HS (1989) Thyroid cancer in children and adolescents in Denmark. Eur J Surg Oncol 15:49–53PubMed
22.
go back to reference Chow SM, Law SC, Mendenhall WM et al (2004) Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine. Pediatr Blood Cancer 42:176–183PubMedCrossRef Chow SM, Law SC, Mendenhall WM et al (2004) Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine. Pediatr Blood Cancer 42:176–183PubMedCrossRef
23.
go back to reference Newman KD, Black T, Heller G et al (1998) Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children’s Cancer Group. Ann Surg 227:533–541PubMedCentralPubMedCrossRef Newman KD, Black T, Heller G et al (1998) Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children’s Cancer Group. Ann Surg 227:533–541PubMedCentralPubMedCrossRef
24.
go back to reference Zimmerman D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1,039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166PubMed Zimmerman D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1,039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166PubMed
25.
go back to reference Palmer BA, Zarroug AE, Poley RN et al (2005) Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence. J Pediatr Surg 40:1284–1288PubMedCrossRef Palmer BA, Zarroug AE, Poley RN et al (2005) Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence. J Pediatr Surg 40:1284–1288PubMedCrossRef
26.
go back to reference Choi JW, Lee JH, Baek JH et al (2010) Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma. Ultrasound Med Biol 36:1608–1615PubMedCrossRef Choi JW, Lee JH, Baek JH et al (2010) Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma. Ultrasound Med Biol 36:1608–1615PubMedCrossRef
27.
go back to reference Park EK, Chung JK, Lim IH et al (2009) Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans. Eur J Nucl Med Mol Imaging 36:172–179PubMedCrossRef Park EK, Chung JK, Lim IH et al (2009) Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans. Eur J Nucl Med Mol Imaging 36:172–179PubMedCrossRef
28.
go back to reference Ma C, Kuang A, Xie J et al (2005) Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning. J Nucl Med 46:1473–1480PubMed Ma C, Kuang A, Xie J et al (2005) Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning. J Nucl Med 46:1473–1480PubMed
29.
go back to reference Spencer C, Petrovic I, Fatemi S (2011) Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96:1283–1291PubMedCrossRef Spencer C, Petrovic I, Fatemi S (2011) Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96:1283–1291PubMedCrossRef
30.
go back to reference Siddiqi A, Foley RR, Britton KE et al (2001) The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning. Clin Endocrinol 55:515–521CrossRef Siddiqi A, Foley RR, Britton KE et al (2001) The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning. Clin Endocrinol 55:515–521CrossRef
31.
go back to reference Brendel AJ, Lambert B, Guyot M et al (1990) Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma. Eur J Nucl Med 16:35–38PubMedCrossRef Brendel AJ, Lambert B, Guyot M et al (1990) Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma. Eur J Nucl Med 16:35–38PubMedCrossRef
32.
go back to reference Bachelot A, Cailleux AF, Klain M et al (2002) Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 12:707–711PubMedCrossRef Bachelot A, Cailleux AF, Klain M et al (2002) Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 12:707–711PubMedCrossRef
33.
go back to reference Torrens JI, Burch HB (2001) Serum thyroglobulin measurement. Utility in clinical practice. Endocrinol Metab Clin North Am 30:429–467PubMedCrossRef Torrens JI, Burch HB (2001) Serum thyroglobulin measurement. Utility in clinical practice. Endocrinol Metab Clin North Am 30:429–467PubMedCrossRef
Metadata
Title
The role of ultrasound in the follow-up of children with differentiated thyroid cancer
Authors
Reza Vali
Marianna Rachmiel
Jill Hamilton
Mohamad El Zein
Jonathan Wasserman
Danny L. Costantini
Martin Charron
Alan Daneman
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 7/2015
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-014-3261-0

Other articles of this Issue 7/2015

Pediatric Radiology 7/2015 Go to the issue